Impact of proteinuria in cyclosporine-treated cadaveric renal transplant recipients.
Koay
H C
HC
Department of Renal Medicine, Singapore General Hospital, Singapore, Philippines.
Vathsala
A
A
Woo
K T
KT
D000328:Adult; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005921:Glomerulonephritis / Q000473:pathology; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006417:Hematuria; D006801:Humans; D006949:Hyperlipidemias / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000401:mortality / Q000473:pathology / Q000502:physiology*; D019520:Living Donors; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology; D011507:Proteinuria; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine